Literature DB >> 18717721

Misdiagnosis in epilepsy: a review and recognition of diagnostic uncertainty.

F A Chowdhury1, L Nashef, R D C Elwes.   

Abstract

The diagnosis of first seizure or epilepsy may be challenging and misdiagnosis can occur. Studies carried out in various settings have reported misdiagnosis rates of between 4.6% and 30%. Misdiagnosis can lead to serious consequences including driving and employment restrictions and inappropriate treatments. Most studies focus on ways of reducing misdiagnosis. However, in some cases, it may be difficult to make a definite diagnosis at initial presentation. This is because of a number of reasons including overlapping clinical features with other conditions, inadequate available history and limitations of investigations. Consequently, diagnostic uncertainty is inevitable in epilepsy, although few studies acknowledge this. In this paper we review the literature on misdiagnosis rates, analyse reasons for misdiagnosis and consider limitations of available investigations. We propose that diagnostic uncertainty in epilepsy should be more widely acknowledged and addressed, and that this may reduce misdiagnosis rates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18717721     DOI: 10.1111/j.1468-1331.2008.02260.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  25 in total

1.  Managing childhood epilepsy in a resource-limited setting: A pragmatic approach.

Authors:  Mohamed Osman Eltahir Babiker
Journal:  Sudan J Paediatr       Date:  2015

Review 2.  [Sudden unexpected death in epilepsy (SUDEP) : Epidemiology, cardiac and other risk factors].

Authors:  Theodor W May; Carsten W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2019-09

3.  Reflex anoxic seizures (RAS) during dry needling.

Authors:  M P Yargic; G B Kurklu
Journal:  Hippokratia       Date:  2019 Jan-Mar       Impact factor: 0.471

4.  Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study.

Authors:  Olli Nevalainen; Jani Raitanen; Hanna Ansakorpi; Miia Artama; Jouko Isojärvi; Anssi Auvinen
Journal:  Eur J Epidemiol       Date:  2013-09-26       Impact factor: 8.082

Review 5.  A guide to disorders causing transient loss of consciousness: focus on syncope.

Authors:  J Gert van Dijk; Roland D Thijs; David G Benditt; Wouter Wieling
Journal:  Nat Rev Neurol       Date:  2009-07-14       Impact factor: 42.937

6.  Early postictal serum lactate concentrations are superior to serum creatine kinase concentrations in distinguishing generalized tonic-clonic seizures from syncopes.

Authors:  Oliver Matz; Jan Heckelmann; Sebastian Zechbauer; Jens Litmathe; Jörg C Brokmann; Klaus Willmes; Jörg B Schulz; Manuel Dafotakis
Journal:  Intern Emerg Med       Date:  2017-09-12       Impact factor: 3.397

7.  Potential misdiagnoses of Bell's palsy in the emergency department.

Authors:  Jahan Fahimi; Babak B Navi; Hooman Kamel
Journal:  Ann Emerg Med       Date:  2013-07-25       Impact factor: 5.721

8.  Subspecialty-Level Deep Gray Matter Differential Diagnoses with Deep Learning and Bayesian Networks on Clinical Brain MRI: A Pilot Study.

Authors:  Jeffrey D Rudie; Andreas M Rauschecker; Long Xie; Jiancong Wang; Michael Tran Duong; Emmanuel J Botzolakis; Asha Kovalovich; John M Egan; Tessa Cook; R Nick Bryan; Ilya M Nasrallah; Suyash Mohan; James C Gee
Journal:  Radiol Artif Intell       Date:  2020-09-23

Review 9.  Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications.

Authors:  Fakher Rahim; Reza Azizimalamiri; Mehdi Sayyah; Alireza Malayeri
Journal:  J Exp Pharmacol       Date:  2021-03-11

10.  Relationship between Tumor Necrosis Factor-Alpha and Neuropeptide Y Expression and Neurological Function Score in Epileptic Children.

Authors:  Li Qiu; Dongli Zhang; Yan Sang; Nuo Zheng; Jiao Chen; Xuan Qiu; Xiaoming Liu
Journal:  Iran J Public Health       Date:  2021-05       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.